These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26040501)

  • 1. Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions.
    Ginwala R; McTish E; Raman C; Singh N; Nagarkatti M; Nagarkatti P; Sagar D; Jain P; Khan ZK
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):36-47. PubMed ID: 26040501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases.
    Ginwala R; Bhavsar R; Moore P; Bernui M; Singh N; Bearoff F; Nagarkatti M; Khan ZK; Jain P
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):403-424. PubMed ID: 32607691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
    Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
    Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
    J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD49d/CD29-integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation.
    Garnier A; Laffont S; Garnier L; Kaba E; Deutsch U; Engelhardt B; Guéry JC
    Eur J Immunol; 2019 Nov; 49(11):2030-2043. PubMed ID: 31318439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
    Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis.
    Jain P; Coisne C; Enzmann G; Rottapel R; Engelhardt B
    J Immunol; 2010 Jun; 184(12):7196-206. PubMed ID: 20483748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
    Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
    CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
    Ferrara G; Errede M; Girolamo F; Morando S; Ivaldi F; Panini N; Bendotti C; Perris R; Furlan R; Virgintino D; Kerlero de Rosbo N; Uccelli A
    Acta Neuropathol; 2016 Jul; 132(1):23-42. PubMed ID: 27026411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.
    Sagar D; Singh NP; Ginwala R; Huang X; Philip R; Nagarkatti M; Nagarkatti P; Neumann K; Ruland J; Andrews AM; Ramirez SH; Khan ZK; Jain P
    Sci Rep; 2017 Jun; 7(1):2707. PubMed ID: 28578388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration.
    Ferrara G; Benzi A; Sturla L; Marubbi D; Frumento D; Spinelli S; Abbotto E; Ivaldi F; von Holtey M; Murone M; Nencioni A; Uccelli A; Bruzzone S
    J Neuroinflammation; 2020 Jul; 17(1):228. PubMed ID: 32736564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
    Thomé R; Moraes AS; Bombeiro AL; Farias Ados S; Francelin C; da Costa TA; Di Gangi R; dos Santos LM; de Oliveira AL; Verinaud L
    PLoS One; 2013; 8(6):e65913. PubMed ID: 23799062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
    Cavone L; Aldinucci A; Ballerini C; Biagioli T; Moroni F; Chiarugi A
    Mult Scler; 2011 Jul; 17(7):794-807. PubMed ID: 21343230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
    Mills JH; Kim DG; Krenz A; Chen JF; Bynoe MS
    J Immunol; 2012 Jun; 188(11):5713-22. PubMed ID: 22529293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
    Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
    Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation.
    Columba-Cabezas S; Serafini B; Ambrosini E; Aloisi F
    Brain Pathol; 2003 Jan; 13(1):38-51. PubMed ID: 12580544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis.
    Warford J; Jones QR; Nichols M; Sullivan V; Rupasinghe HP; Robertson GS
    J Neuroimmunol; 2014 Mar; 268(1-2):71-83. PubMed ID: 24485149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.